OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 104 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,000 | -27.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | -67.6% | 20,000 | 0.0% | 0.00% | – |
| Q4 2015 | $34,000 | -22.7% | 20,000 | -4.8% | 0.00% | – |
| Q3 2015 | $44,000 | -55.6% | 21,000 | +5.0% | 0.00% | -100.0% |
| Q2 2015 | $99,000 | -36.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $156,000 | +28.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $121,000 | +188.1% | 20,000 | +100.0% | 0.00% | – |
| Q3 2014 | $42,000 | -99.8% | 10,000 | -99.6% | 0.00% | -100.0% |
| Q2 2014 | $17,366,000 | -36.5% | 2,810,055 | -33.3% | 0.11% | -38.9% |
| Q1 2014 | $27,365,000 | -2.0% | 4,210,055 | -15.2% | 0.18% | -2.7% |
| Q4 2013 | $27,934,000 | -13.2% | 4,961,790 | -5.5% | 0.18% | -17.8% |
| Q3 2013 | $32,170,000 | -31.3% | 5,247,990 | -14.6% | 0.22% | -30.1% |
| Q2 2013 | $46,860,000 | – | 6,141,636 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 525,000 | $2,956,000 | 1.06% |
| First Light Asset Management, LLC | 170,804 | $962,000 | 0.82% |
| PFM Health Sciences, LP | 5,047,119 | $28,415,000 | 0.57% |
| Rhenman & Partners Asset Management AB | 250,000 | $1,408,000 | 0.55% |
| NEA Management Company, LLC | 1,935,300 | $10,896,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 544,779 | $3,067,000 | 0.43% |
| APEX CAPITAL, LLC | 1,000,000 | $5,630,000 | 0.37% |
| Partner Investment Management, L.P. | 240,221 | $1,352,000 | 0.31% |
| Hudson Bay Capital Management LP | 1,002,405 | $5,644,000 | 0.23% |
| BAILARD, INC. | 243,300 | $1,370,000 | 0.22% |